76 related articles for article (PubMed ID: 9828102)
1. Cisplatin induced intermediate filament reorganization and altered mitochondrial function in 3T3 cells and drug-sensitive and -resistant Walker 256 cells.
Evans RM; Simpkins H
Exp Cell Res; 1998 Nov; 245(1):69-78. PubMed ID: 9828102
[TBL] [Abstract][Full Text] [Related]
2. Intermediate filaments in biology and disease.
Revis Biol Celular; 1989; 22():1-80. PubMed ID: 2699767
[TBL] [Abstract][Full Text] [Related]
3. alphaB-crystallin interacts with cytoplasmic intermediate filament bundles during mitosis.
Djabali K; Piron G; de Néchaud B; Portier MM
Exp Cell Res; 1999 Dec; 253(2):649-62. PubMed ID: 10585288
[TBL] [Abstract][Full Text] [Related]
4. Chromatin motion in neuronal interphase nuclei: changes induced by disruption of intermediate filaments.
Hay M; De Boni U
Cell Motil Cytoskeleton; 1991; 18(1):63-75. PubMed ID: 2004434
[TBL] [Abstract][Full Text] [Related]
5. Characterization of mitochondria in cisplatin-resistant human ovarian carcinoma cells.
Hirama M; Isonishi S; Yasuda M; Ishikawa H
Oncol Rep; 2006 Nov; 16(5):997-1002. PubMed ID: 17016583
[TBL] [Abstract][Full Text] [Related]
6. Nuclear and mitochondrial distribution of organoamidoplatinum(II) lesions in cisplatin-sensitive and -resistant adenocarcinoma cells.
Talarico T; Cullinane CM; Gray PJ; Webster LK; Deacon GB; Phillips DR
Anticancer Drug Des; 2001; 16(2-3):135-41. PubMed ID: 11962511
[TBL] [Abstract][Full Text] [Related]
7. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
O'Neill CF; Koberle B; Masters JR; Kelland LR
Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
[TBL] [Abstract][Full Text] [Related]
8. Influence of triethyl lead on neurofilaments in vivo and in vitro.
Zimmermann HP; Plagens U; Traub P
Neurotoxicology; 1987; 8(4):569-77. PubMed ID: 3126465
[TBL] [Abstract][Full Text] [Related]
9. Regulated expression of human filaggrin in keratinocytes results in cytoskeletal disruption, loss of cell-cell adhesion, and cell cycle arrest.
Presland RB; Kuechle MK; Lewis SP; Fleckman P; Dale BA
Exp Cell Res; 2001 Nov; 270(2):199-213. PubMed ID: 11640884
[TBL] [Abstract][Full Text] [Related]
10. Alteration of the distribution of intermediate filaments in PtK1 cells by acrylamide. II: Effect on the organization of cytoplasmic organelles.
Eckert BS
Cell Motil Cytoskeleton; 1986; 6(1):15-24. PubMed ID: 3698106
[TBL] [Abstract][Full Text] [Related]
11. Hexahydrocarbon effects on intermediate filament organization in human fibroblasts.
Durham HD; Peña SD; Ecobichon DJ
Muscle Nerve; 1988 Feb; 11(2):160-5. PubMed ID: 3343992
[TBL] [Abstract][Full Text] [Related]
12. Effects of cisplatin on mitochondrial function in Jurkat cells.
Tacka KA; Dabrowiak JC; Goodisman J; Penefsky HS; Souid AK
Chem Res Toxicol; 2004 Aug; 17(8):1102-11. PubMed ID: 15310242
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin impairs rat liver mitochondrial functions by inducing changes on membrane ion permeability: prevention by thiol group protecting agents.
Custódio JB; Cardoso CM; Santos MS; Almeida LM; Vicente JA; Fernandes MA
Toxicology; 2009 May; 259(1-2):18-24. PubMed ID: 19428939
[TBL] [Abstract][Full Text] [Related]
15. Impaired activation of caspases and prevention of mitochondrial dysfunction in the metastatic colon carcinoma CC531s-m2 cell line.
Velthuis JH; Gavric Z; de Bont HJ; Nagelkerke JF
Biochem Pharmacol; 2005 Feb; 69(3):463-71. PubMed ID: 15652237
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-mediated impairment of mitochondrial DNA metabolism inversely correlates with glutathione levels.
Garrido N; Pérez-Martos A; Faro M; Lou-Bonafonte JM; Fernández-Silva P; López-Pérez MJ; Montoya J; Enríquez JA
Biochem J; 2008 Aug; 414(1):93-102. PubMed ID: 18426391
[TBL] [Abstract][Full Text] [Related]
17. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Alas S; Ng CP; Bonavida B
Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
[TBL] [Abstract][Full Text] [Related]
18. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
Donnelly ET; Kelley M; Rockwell S
Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
[TBL] [Abstract][Full Text] [Related]
19. Differential induction of apoptosis and MAP kinase signaling by mitochondrial toxicants in drug-sensitive compared to drug-resistant B-lineage lymphoid cell lines.
O'Brien KA; Muscarella DE; Bloom SE
Toxicol Appl Pharmacol; 2001 Aug; 174(3):245-56. PubMed ID: 11485385
[TBL] [Abstract][Full Text] [Related]
20. Basic fibroblast growth factor sensitizes NIH 3T3 cells to apoptosis induced by cisplatin.
Coleman AB; Momand J; Kane SE
Mol Pharmacol; 2000 Feb; 57(2):324-33. PubMed ID: 10648642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
